drugset

drugset / Trial / NCT03998215

Diphtheria Vaccination in Adolescents With Inflammatory Bowel Disease

NCT03998215 ↗

Completed 46 enrolled Medical University of Warsaw Medical University of Silesia · collab Poznan University of Medical Sciences · collab Wroclaw Medical University · collab

NaSingle-groupOpen-labelPrevention

Summary

Assessment of the immunogenicity and safety of booster immunization against diphtheria in children with inflammatory bowel disease.

Timeline

Start: 2012-12-01
Primary completion: 2015-01-01
Completion: 2015-01-01

Publications

Dembinski L, Krzesiek E, Klincewicz B, Grzybowska-Chlebowczyk U, Demkow U, Banaszkiewicz A, Radzikowski A. Immunogenicity of Diphtheria Booster Vaccination in Adolescents With Inflammatory Bowel Disease. Pediatr Infect Dis J. 2020 Mar;39(3):244-246. doi: 10.1097/INF.0000000000002547.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Diphtheria booster vaccination	Vaccine	—	Intramuscular

Indications